Arachidonic Acid and Docosahexaenoic Acid Metabolites in the Airways of Adults With Cystic Fibrosis: Effect of Docosahexaenoic Acid Supplementation
Cystic fibrosis (CF) is an autosomal recessive disorder, caused by genetic mutations in CF transmembrane conductance regulator protein. Several reports have indicated the presence of specific fatty acid alterations in CF patients, most notably decreased levels of plasmatic and tissue docosahexaenoic...
Main Authors: | Elisabetta Teopompi, Patrizia Risé, Roberta Pisi, Carola Buccellati, Marina Aiello, Giovanna Pisi, Candida Tripodi, Valentina Fainardi, Enrico Clini, Alfredo Chetta, G. Enrico Rovati, Angelo Sala |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-08-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2019.00938/full |
Similar Items
-
Impact of Arachidonic and Docosahexaenoic Acid Supplementation on Neural and Immune Development in the Young Pig
by: Kaylee E. Hahn, et al.
Published: (2020-10-01) -
Identification and absolute configuration of dihydroxy-arachidonic acids formed by oxygenation of 5S-HETE by native and aspirin-acetylated COX-2
by: Surafel Mulugeta, et al.
Published: (2010-03-01) -
A Diet With Docosahexaenoic and Arachidonic Acids as the Sole Source of Polyunsaturated Fatty Acids Is Sufficient to Support Visual, Cognitive, Motor, and Social Development in Mice
by: Sarah J. Carlson, et al.
Published: (2019-02-01) -
Do Eicosapentaenoic Acid and Docosahexaenoic Acid Have the Potential to Compete against Each Other?
by: Anandita Pal, et al.
Published: (2020-12-01) -
Docosahexaenoic and Arachidonic Acids as Neuroprotective Nutrients throughout the Life Cycle
by: Verónica Sambra, et al.
Published: (2021-03-01)